Position in CRIS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,852
+$44,082 QoQ
Shares Held
4,794
+813.1% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 36 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRIS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. CRIS ranks #377 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CRIS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,852 | 95,870 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,770 | 10,492 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $10,387 | 10,492 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $71,360 | 42,988 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $106,527 | 45,917 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $98,263 | 46,792 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $145,074 | 47,410 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $255,539 | 47,410 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $84,980 | 12,316 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $114,232 | 10,509 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $199,716 | 15,664 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $127,103 | 153,136 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $108,627 | 182,260 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $90,176 | 163,957 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $115,000 | 163,957 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $161,000 | 163,957 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,912,000 | 802,958 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,994,000 | 838,975 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $7,641,000 | 975,786 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,150,000 | 1,009,927 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,699,000 | 150,047 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $830,000 | 101,404 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $94,000 | 79,951 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $73,000 | 59,816 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $42,000 | 58,657 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||